August 10, 2017 / 11:30 AM / a month ago

BRIEF-Recro Pharma quarterly ‍loss per share $0.48

Aug 10 (Reuters) - Recro Pharma Inc

* Recro Pharma reports second quarter 2017 financial results

* Q2 revenue $16.9 million versus i/b/e/s view $14.6 million

* Qtrly ‍loss per share $0.48; Co is raising its guidance for 2017 revenue from a range of $55-$60 million to $60-$63 million​ Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below